NDT Advance Access published online on February 19, 2004
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh129
© 2004 by European Renal Association - European Dialysis and Transplant Association
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 School of Clinical Medical Sciences, Medical School, University of Newcastle upon Tyne, UK
* To whom correspondence should be addressed. E-mail: k.e.white{at}ncl.ac.uk.
Background. The podocyte is believed to play a key role in maintaining the integrity of the glomerular filtration barrier, and damage or loss has been linked to the development of albuminuria. Methods. Renal biopsies from 16 type 2 diabetic patients with nephropathy and 28 non-diabetic controls were analysed using light and electron microscopy. Results. Podocyte number per glomerulus was significantly lower in the type 2 patients compared with controls [mean (95% confidence interval) 464 (382-546) vs 589 (543-635), P = 0.004]. Mean glomerular volume was significantly increased in diabetic patients compared with controls [5.5 (4.9-6.1) vs 3.1 (2.7-3.5) x 106 µm3, P<0.001], thus the diabetic patients demonstrated an even greater proportional reduction in podocyte density per glomerulus [88 (68-108) vs 201 (182-220)/106 µm3, P<0.001]. Podocyte foot process width on both the filtration surface (FPWgbm) and mesangial surface (FPWmes) was significantly increased compared with controls [796 (708-884) vs 556 (460-908) nm, P = 0.001; 1108 (821-1394) vs 760 (555-1078) nm, P = 0.029, respectively]. There was a significant negative correlation between proteinuria and both podocyte number and podocyte density per glomerulus (r = -0.63, P = 0.009; r = -0.58, P = 0.018, respectively). There was a significant positive correlation between proteinuria and both FPWgbm and FPWmes (r = 0.64, P = 0.008, for both). Conclusion. Podocyte loss occurs in type 2 diabetic nephropathy and is related to increasing proteinuria. Whether the accompanying glomerular enlargement and widening of foot processes are a cause of podocyte loss is uncertain. Longitudinal studies are required to determine the sequence of events leading to podocyte loss in diabetic nephropathy.
Accepted December 19, 2003
Original Article
Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Lennon, D. Pons, M. A. Sabin, C. Wei, J. P. Shield, R. J. Coward, J. M. Tavare, P. W. Mathieson, M. A. Saleem, and G. I. Welsh Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3288 - 3296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dessapt, M. O. Baradez, A. Hayward, A. Dei Cas, S. M. Thomas, G. Viberti, and L. Gnudi Mechanical forces and TGF{beta}1 reduce podocyte adhesion through {alpha}3{beta}1 integrin downregulation Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2645 - 2655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. White, S. M. Marshall, and R. W. Bilous Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3539 - 3545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Toyoda, B. Najafian, Y. Kim, M. L. Caramori, and M. Mauer Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy Diabetes, August 1, 2007; 56(8): 2155 - 2160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Dandapani, H. Sugimoto, B. D. Matthews, R. J. Kolb, S. Sinha, R. E. Gerszten, J. Zhou, D. E. Ingber, R. Kalluri, and M. R. Pollak {alpha}-Actinin-4 Is Required for Normal Podocyte Adhesion J. Biol. Chem., January 5, 2007; 282(1): 467 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen Blockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in Mice J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3093 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Opocensky, H. J. Kramer, A. Backer, Z. Vernerova, V. Eis, L. Cervenka, V. Certikova Chabova, V. Tesar, and I. Vaneckova Late-Onset Endothelin-A Receptor Blockade Reduces Podocyte Injury in Homozygous Ren-2 Rats Despite Severe Hypertension Hypertension, November 1, 2006; 48(5): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Zhao, S. Wang, H. Cheng, M.-z. Zhang, T. Takahashi, A. B. Fogo, M. D. Breyer, and R. C. Harris Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2664 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Macconi, M. Bonomelli, A. Benigni, T. Plati, F. Sangalli, L. Longaretti, S. Conti, H. Kawachi, P. Hill, G. Remuzzi, et al. Pathophysiologic Implications of Reduced Podocyte Number in a Rat Model of Progressive Glomerular Injury Am. J. Pathol., January 1, 2006; 168(1): 42 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J.M. Coward, G. I. Welsh, J. Yang, C. Tasman, R. Lennon, A. Koziell, S. Satchell, G. D. Holman, D. Kerjaschki, J. M. Tavare, et al. The Human Glomerular Podocyte Is a Novel Target for Insulin Action Diabetes, November 1, 2005; 54(11): 3095 - 3102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wolf, S. Chen, and F. N. Ziyadeh From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy Diabetes, June 1, 2005; 54(6): 1626 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ortmann, K. Amann, R. P. Brandes, M. Kretzler, K. Munter, N. Parekh, T. Traupe, M. Lange, T. Lattmann, and M. Barton Role of Podocytes for Reversal of Glomerulosclerosis and Proteinuria in the Aging Kidney After Endothelin Inhibition Hypertension, December 1, 2004; 44(6): 974 - 981. [Abstract] [Full Text] [PDF]
|
|